Ascendis Pharma A (ASND) EBITDA Margin Growth (3y) (2017 - 2026)
Ascendis Pharma A (ASND) EBITDA Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ascendis Pharma A | 15.31 Bn | 14.64 Bn | 268.20 Mn | 43,784.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43,784.00 |
| Dec 31, 2025 | 64,613.00 |
| Sep 30, 2025 | 95,024.00 |
| Jun 30, 2025 | 226,995.00 |
| Mar 31, 2025 | 177,183.00 |
| Dec 31, 2024 | 12.37 Mn |
| Sep 30, 2024 | 854,179.00 |
| Jun 30, 2024 | 1.11 Mn |
| Mar 31, 2024 | 1.67 Mn |
| Dec 31, 2023 | 12,629.00 |
| Sep 30, 2023 | 257,927.00 |
| Jun 30, 2023 | 547,908.00 |
| Mar 31, 2023 | 286,234.00 |
| Dec 31, 2022 | -48,342.00 |
| Sep 30, 2022 | 146,306.00 |
| Jun 30, 2022 | -69,726.00 |
| Mar 31, 2022 | -83,551.00 |
| Dec 31, 2021 | 1,707.00 |
| Sep 30, 2021 | -870,888.00 |
| Jun 30, 2021 | 24.10 Mn |